Skip to content

Atopic Dermatitis

NO LONGER ACCEPTING APPLICATIONS
Published on:
October 29, 2024
Sign-up Expiration:
Updated:
Topics:
Locations:

Do you suffer from atopic dermatitis (eczema)?

You may be interested in a study for people diagnosed with atopic dermatitis.

Those who qualify will receive the investigational medication, as well as study-related medical exams and laboratory tests, all at no cost, and if you qualify you may receive reimbursement for travel.

The purpose of the study is to assess the efficacy and safety of Upadacitinib compared with Dupilumab as per its label, in adult subjects with inadequate response to Dupilumab.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED